<DOC>
	<DOCNO>NCT00263809</DOCNO>
	<brief_summary>The primary objective study measure platelet correct count increment incidence serious adverse event ( SAE ) . The primary endpoint platelet correct count increment measure 1-hour post transfusion response infusion platelet concentrate treat Mirasol PRT System device ( test product ) versus untreated ( reference product ) .</brief_summary>
	<brief_title>Safety Performance MIRASOLÂ® PRT Treated Platelet Transfusion Products</brief_title>
	<detailed_description>The objective study determine MIRASOL Pathogen Reduction Technology ( PRT ) System Platelets device performs safely maintain adequate platelet performance clinical setting . This achieve compare platelet correct count increment measure 1 hour post transfusion incidence serious adverse event response infusion platelet concentrate treat device ( test product ) versus untreated ( reference product ) thrombocytopenic subject require platelet transfusion . The performance , safety , tolerability profile device assess monitor compare incidence discontinuation due adverse event relation platelet transfusion 4 week transfusion , include incidence transfusion associate infection , number time transfusion .</detailed_description>
	<mesh_term>Thrombocytopenia</mesh_term>
	<criteria>Male female age 16 year old Women Child Bearing Potential pregnant Subject must sign date Informed Consent form Hospitalized , thrombocytopenic subject expect receive least two platelet transfusion History hypersensitivity reaction riboflavin metabolites History refractoriness platelet transfusion Positive lymphocytotoxic antibody test Active bleeding Splenomegaly Acute chronic Disseminated Intravascular Coagulation History diagnosis Immune/Idiopathic Thrombocytopenic Purpura , Thrombotic Thrombocytopenia Purpura , Haemolytic Uremic Syndrome History diagnosis autoimmune disease affect haemostasis History solid organ transplant Evidence occlusive venous disease Clinical sign infection time inclusion Pregnant lactating female Chronic alcohol misuse Use prohibit medication</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>